White House drafts executive order to control N.I.H. grants
by@nytimes
Summary
Federal officials are drafting an executive order that would enhance President Trump's ability to control billions of dollars in scientific grants administered by the National Institutes of Health (N.I.H.). This initiative, discussed during a contentious meeting at the White House, aims to establish a new external committee with the authority to veto grant awards that do not align with Mr. Trump's political agenda. The N.I.H., a $48 billion agency that plays a crucial role in funding biomedical research for significant health issues, has reaffirmed its commitment to serving the health of the American people, despite concerns over potential political interference in its grant-making process.
Analysis
White House: The White House serves as the official residence and workplace of the President of the United States and coordinates executive branch policy and operations across federal agencies. In this development, it is leading efforts to draft an executive order that would establish new oversight for scientific grant decisions at the National Institutes of Health. Joshua Pradko: Joshua Pradko serves as a spokesman for the National Institutes of Health, communicating official positions on agency operations and funding. He addressed recent reports by reaffirming the agency's commitment to its biomedical research mission and stating that all grant funds will be expended as planned. President Trump: Donald Trump is the current President of the United States, directing executive branch actions and policy implementation including agency funding decisions. Reports indicate his administration seeks expanded authority to shape National Institutes of Health research awards according to political criteria. National Institutes of Health: The National Institutes of Health is the primary U.S. federal agency for biomedical and public health research, distributing funds to labs and institutions nationwide. The news centers on White House plans to influence its grant portfolio through a proposed external review committee aligned with administration priorities. Agency Position: National Institutes of Health representatives have publicly stated the agency remains focused on funding research that benefits American health. Executive Oversight: The White House is preparing an executive order to form an external committee with veto power over certain National Institutes of Health grant awards.
Categories
politicsmacro